Cell Therapy
The latest news about Cell Therapy: headlines, AI summaries and the full story from every source.
- Repligen Reports Record Q3 Revenue and Strategic Expansion into Cell Therapy
- CareDx Raises 2026 Revenue Guidance Amid Expansion into Oncology and Cell Therapy
- Persista Bio Receives Positive FDA Feedback on Modular Cell Therapy System for Type 1 Diabetes
- Cell Therapy Manufacturer Acquires Facility to Expand Operations Near Philadelphia
- Allogene Therapeutics Receives FDA RMAT and Fast Track Designations for Cell Therapy Candidate
- Leadership Changes at Legend Biotech and Sarepta Therapeutics
- Repligen to Acquire BioLife in $1.5 Billion Deal
- Iovance Biotherapeutics Updates Corporate Presentation with Key Financials and Pipeline Progress
- Eli Lilly's Recent Acquisitions in Diverse Therapeutic Areas
- FDA Issues Draft Guidance to Accelerate Gene Therapy Development
- ProKidney Appoints Greg Madison as Chief Commercial Officer to Lead Rilparencel Strategy
- Obsidian Therapeutics to Begin Trading on Nasdaq After Reverse Merger with Galera Therapeutics